EVEREST MEDICINES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.35 HKD | -4.11% |
|
-10.36% | +11.72% |
| 05-14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
| 05-14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVEREST MEDICINES LIMITED | Biopharmaceuticals | -4.11% | -10.36% | +11.72% | +75.56% | - | 959M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 1952 Stock
- Charts Everest Medicines Limited
- Comparison Chart
